Decreased glutathione transferase activity in brain and ventricular fluid in Alzheimer's disease

Objective: To investigate the levels of glutathione transferase (GST), a protective enzyme against aldehydes, and especially 4-hydroxynonenal (HNE) in the brain and ventricular CSF of autopsied AD and normal control subjects. Background: Studies have implicated increased levels of oxidative stress in the brain in the pathogenesis of AD. Decreased levels of polyunsaturated fatty acids and increased levels of markers of lipid peroxidation have been reported in the brain in AD, particularly in areas severely affected in the disease. HNE, one marker of lipid peroxidation, is neurotoxic in neuronal culture and in vivo and is elevated in AD brain and CSF. Methods: We measured levels of GST activity and protein in multiple brain regions and ventricular CSF in short-postmortem-interval AD patients and age-matched prospectively evaluated control subjects. Results: A decrease in GST activity in all brain areas was observed in AD compared with controls with significant decreases in the amygdala, hippocampus and parahippocampal gyrus, inferior parietal lobule, and nucleus basalis of Meynert. Levels of GST protein also were depleted in most brain regions in AD. A significant decrease in GST activity and protein levels was also found in ventricular CSF in AD. Conclusion: Reduced levels of GST, a protective mechanism against HNE, may have a role in the pathogenesis of neuron degeneration in AD.

[1]  A. Caccuri,et al.  Colorimetric and fluorometric assays of glutathione transferase based on 7-chloro-4-nitrobenzo-2-oxa-1,3-diazole. , 1994, Analytical biochemistry.

[2]  J. Miller,et al.  Influence of the major histocompatibility complex on T-cell activation. , 1979, Advances in cancer research.

[3]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[4]  H. Jörnvall,et al.  Structural evidence for three different types of glutathione transferase in human tissues , 1985, FEBS letters.

[5]  J. Ferrendelli.  Lennox‐gastaut syndrome and positron emission tomography , 1987, Annals of neurology.

[6]  Scott T. Grafton,et al.  Cortical control of movement , 1994, Annals of neurology.

[7]  B. Ketterer,et al.  THE ROLE OF INTRACELLULAR PROTEINS IN THE TRANSPORT AND METABOLISM OF LIPOPHILIC COMPOUNDS , 1978 .

[8]  W. D. Ehmann,et al.  Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease , 1995, Neurology.

[9]  B. Mannervik,et al.  Molecular and catalytic properties of glutathione transferase mu from human liver: an enzyme efficiently conjugating epoxides. , 1983, Biochemistry.

[10]  M. Mattson,et al.  4-Hydroxynonenal, a Product of Lipid Peroxidation, Damages Cholinergic Neurons and Impairs Visuospatial Memory in Rats , 1998, Journal of neuropathology and experimental neurology.

[11]  Mark A. Smith,et al.  4‐Hydroxynonenal‐Derived Advanced Lipid Peroxidation End Products Are Increased in Alzheimer's Disease , 1997, Journal of neurochemistry.

[12]  H. Wiśniewski,et al.  Pathology of Alzheimer's disease. , 1991, The Psychiatric clinics of North America.

[13]  D. Butterfield,et al.  Brain Regional Correspondence Between Alzheimer's Disease Histopathology and Biomarkers of Protein Oxidation , 1995, Journal of neurochemistry.

[14]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[15]  L. F. Chasseaud,et al.  The role of glutathione and glutathione S-transferases in the metabolism of chemical carcinogens and other electrophilic agents. , 1979, Advances in cancer research.

[16]  B. Mannervik,et al.  Structure-activity relationships of 4-hydroxyalkenals in the conjugation catalysed by mammalian glutathione transferases. , 1987, The Biochemical journal.

[17]  H. Jörnvall,et al.  Gene expression of rat and human microsomal glutathione S-transferases. , 1988, The Journal of biological chemistry.

[18]  Patrizia Mecocci,et al.  Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease , 1994, Annals of neurology.

[19]  B. Mannervik,et al.  Purification of a new glutathione S-transferase (transferase mu) from human liver having high activity with benzo(alpha)pyrene-4,5-oxide. , 1981, Biochemical and biophysical research communications.

[20]  B. Ketterer,et al.  Theta, a new class of glutathione transferases purified from rat and man. , 1991, The Biochemical journal.

[21]  M. Mattson,et al.  A Role for 4‐Hydroxynonenal, an Aldehydic Product of Lipid Peroxidation, in Disruption of Ion Homeostasis and Neuronal Death Induced by Amyloid β‐Peptide , 1997, Journal of neurochemistry.

[22]  H. Esterbauer,et al.  Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. , 1991, Free radical biology & medicine.

[23]  D. Schubert,et al.  Band 3 protein—cholesterol interactions in erythrocyte membranes , 1982, FEBS letters.

[24]  R. Rosenberg.  Autosomal dominant cerebellar phenotypes , 1990, Neurology.

[25]  S. Daniel,et al.  Glutathione‐related enzymes in brain in Parkinson's disease , 1994, Annals of neurology.

[26]  J. Cano,et al.  Chronic inhibition of the high-affinity dopamine uptake system increases oxidative damage to proteins in the aged rat substantia nigra. , 1997, Free radical biology & medicine.

[27]  R. Estabrook,et al.  Novel glutathione conjugates formed from epoxyeicosatrienoic acids (EETs). , 1985, Archives of biochemistry and biophysics.

[28]  E. Christ-Hazelhof,et al.  Conversions of prostaglandin endoperoxides by glutathione-S-transferases and serum albumins. , 1976, Biochimica et biophysica acta.

[29]  W. Markesbery,et al.  Glutathione transferase protects neuronal cultures against four hydroxynonenal toxicity. , 1998, Free radical biology & medicine.

[30]  K. Hashimoto,et al.  Role of central angiotensinergic mechanism in shaking stress-induced ACTH and catecholamine secretion , 1990, Brain Research.

[31]  T. Arendt,et al.  Phosphorylation of Tau, Aβ-Formation, and Apoptosis After In Vivo Inhibition of PP-1 and PP-2A , 1998, Neurobiology of Aging.

[32]  H. Jörnvall,et al.  Identification of three classes of cytosolic glutathione transferase common to several mammalian species: correlation between structural data and enzymatic properties. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[33]  T. Montine,et al.  4‐Hydroxy‐2‐Nonenal Pyrrole Adducts in Human Neurodegenerative Disease , 1997, Journal of neuropathology and experimental neurology.

[34]  W. Markesbery,et al.  Four-Hydroxynonenal, a Product of Lipid Peroxidation, is Increased in the Brain in Alzheimer’s Disease , 1998, Neurobiology of Aging.

[35]  W. Markesbery,et al.  Trace element imbalances in isolated subcellular fractions of Alzheimer's disease brains , 1990, Brain Research.

[36]  V. Yong,et al.  Amino acids, glutathione, and glutathione transferase activity in the brains of patients with Alzheimer's disease , 1987, Annals of neurology.